ライフサイエンスコーパス: AIDS-related lymphoma

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 of rapamycin (mTORC)1 pathway in 29 cases of AIDS-related lymphoma.

2 to improve success rates in the treatment of AIDS-related lymphoma.

3 e P-glycoprotein-mediated drug resistance in AIDS-related lymphoma.

4 coprotein is an adverse prognostic factor in AIDS-related lymphoma.

5 pact on response to therapy in patients with AIDS-related lymphoma.

6 se observed in Epstein-Barr virus-associated AIDS-related lymphoma.

7 ve, in contrast to non-HIV PCNSL and non-CNS AIDS-related lymphomas.

8 kin's disease, nasopharyngeal carcinoma, and AIDS-related lymphomas.

9 ected B-lymphocyte cell line derived from an AIDS-related lymphoma and a genomic library made from a

10 These findings indicate that AIDS-related lymphoma and other histologically similar t

11 ARL (acquired immunodeficiency syndrome (AIDS)-related lymphoma) and non-ARL cell lines have been

12 aposi's sarcoma (KS), from a small subset of AIDS-related lymphomas, and from a high proportion of mu

13 in hairy leukoplakia lesions, in a subset of AIDS-related lymphomas, and in saliva from HIV-positive

14 nesis of acquired immunodeficiency syndrome (AIDS)-related lymphoma (ARL), we studied 14 cases in whi

15 s of the acquired immunodeficiency syndrome (AIDS)-related lymphoma (ARL).

16 Approximately two thirds of AIDS-related lymphoma (ARL) cases are categorized as dif

17 , pathologic, or clinical characteristics of AIDS-related lymphoma (ARL) over the course of the AIDS

18 Although AIDS-related lymphomas (ARLs) are frequently associated

19 AIDS-related lymphomas (ARLs) are high-grade B-cell lymp

20 chemotherapy is efficacious in patients with AIDS-related lymphoma, but it may be difficult to admini

21 sed incidence of de-novo MDR-1 expression in AIDS-related lymphoma compared with lymphoma in the non-

22 Three hundred sixty-three patients with AIDS-related lymphoma diagnosed from 1982 to 2003 were r

23 AIDS-related lymphoma has a decreased response rate and

24 rides in the management of patients with HIV/AIDS-related lymphomas have been made in recent years.

25 indicated that MneRV2 plays a causal role in AIDS-related lymphomas in macaques.

26 MDR-1 expression in AIDS-related lymphoma is associated with poor response t

27 Among patients without HIV/AIDS-related lymphoma, lung cancer risks were significan

28 Patients with HIV/AIDS-related lymphoma (n = 932) were predominantly diagn

29 ntified in an uncommonly occurring subset of AIDS-related lymphomas, referred to as body-cavity-based

30 ighly active antiretroviral therapy (HAART), AIDS-related lymphoma remains common.

31 eukoplakia lesions and in the EBV-associated AIDS-related lymphomas strengthens the etiologic relatio

32 The incidence of some AIDS-related lymphoma subtypes has changed since the int

33 /HHV-8) in an uncommon and unusual subset of AIDS-related lymphomas that grow mainly in the body cavi

34 Patients with AIDS-related lymphoma usually have extensive lymphomatou

35 ned plasma from 14 consecutive patients with AIDS-related lymphoma with multiplex Ig primers.

36 atients with multiply relapsed or refractory AIDS-related lymphoma, with acceptable toxicity.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。